» Articles » PMID: 37057102

Early Growth Response-1: Key Mediators of Cell Death and Novel Targets for Cardiovascular Disease Therapy

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Significance: Cardiovascular diseases are seen to be a primary cause of death, and their prevalence has significantly increased across the globe in the past few years. Several studies have shown that cell death is closely linked to the pathogenesis of cardiovascular diseases. Furthermore, many molecular and cellular mechanisms are involved in the pathogenesis of the cardiac cell death mechanism. One of the factors that played a vital role in the pathogenesis of cardiac cell death mechanisms included the early growth response-1 () factor.

Recent Advances: Studies have shown that abnormal expression is linked to different animal and human disorders like heart failure and myocardial infarction. The biosynthesis of regulates its activity. can be triggered by many factors such as serum, cytokines, hormones, growth factors, endotoxins, mechanical injury, hypoxia, and shear stress. It also displays a pro-apoptotic effect on cardiac cells, under varying stress conditions. EGR1 mediates a broad range of biological responses to oxidative stress and cell death by combining the acute changes occurring in the cellular environment with sustained changes in gene expression.

Future Directions: The primary regulatory role played by the -targeting DNAzymes, microRNAs, and oligonucleotide decoy strategies in cardiovascular diseases were identified to provide a reference to identify novel therapeutic targets for cardiovascular diseases.

Citing Articles

Cardioprotective effects of hUCMSCs-Exosi-EGR1 MN patch in MI/RI by modulating oxidative stress and mitophagy.

Huang C, Zhang X, Wu S, Chang Q, Zheng Z, Xu J Mater Today Bio. 2025; 31:101500.

PMID: 39944530 PMC: 11815289. DOI: 10.1016/j.mtbio.2025.101500.


Identification of PPREs and PPRE associated genes in the human genome: insights into related kinases and disease implications.

Saha P, Talwar P Front Immunol. 2024; 15:1457648.

PMID: 39434882 PMC: 11491715. DOI: 10.3389/fimmu.2024.1457648.


Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH.

Lhomme L, Sermikli B, Haas J, Fleury S, Quemener S, Guinot V Nat Commun. 2024; 15(1):7173.

PMID: 39169003 PMC: 11339436. DOI: 10.1038/s41467-024-51078-2.


miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes.

Yang Q, Murata K, Ikeda T, Minatoya K, Masumoto H Sci Rep. 2024; 14(1):14811.

PMID: 38926457 PMC: 11208498. DOI: 10.1038/s41598-024-65373-x.


Anshen Shumai Decoction inhibits post-infarction inflammation and myocardial remodeling through suppression of the p38 MAPK/c-FOS/EGR1 pathway.

Wang J, Ye X, Wang Y J Mol Histol. 2024; 55(4):437-454.

PMID: 38874870 DOI: 10.1007/s10735-024-10214-4.


References
1.
Yamasaki K, Asai T, Shimizu M, Aoki M, Hashiya N, Sakonjo H . Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther. 2003; 10(4):356-64. DOI: 10.1038/sj.gt.3301875. View

2.
Coyne L, Chen X . mPOS is a novel mitochondrial trigger of cell death - implications for neurodegeneration. FEBS Lett. 2017; 592(5):759-775. PMC: 5851816. DOI: 10.1002/1873-3468.12894. View

3.
Zins K, Pomyje J, Hofer E, Abraham D, Lucas T, Aharinejad S . Egr-1 upregulates Siva-1 expression and induces cardiac fibroblast apoptosis. Int J Mol Sci. 2014; 15(1):1538-53. PMC: 3907885. DOI: 10.3390/ijms15011538. View

4.
Wu X, Li Y, Zhang S, Zhou X . Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021; 11(7):3052-3059. PMC: 7847684. DOI: 10.7150/thno.54113. View

5.
OConnor D, Bergamaschi D, Trigiante G, Hsieh J, Zhong S, Campargue I . ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001; 8(4):781-94. DOI: 10.1016/s1097-2765(01)00367-7. View